Meda AB

Meda AB is a specialty pharmaceutical company, headquartered in Solna, Sweden. At the end of 2014, Meda had 5,202 employees. Meda's pharmaceuticals are sold in more than 150 countries.[1]

Meda AB
ISINSE0000221723 
Industrypharmaceutical industry 
Founded1995 
Headquarters,
Sweden
Revenue>kr 15,000,000,000 (2014)
Number of employees
5,202 (2014)
ParentMylan 
Websitewww.meda.se/ 

Meda was listed on the Stockholm stock market until it was acquired by Mylan in 2016 through a cash and stock offer.

Mergers, acquisitions and divestments

In 2014, Meda acquired the Italian firm RottaPharm Madaus in order to add consumer health products to their portfolio.[2] Meda explored in 2015 the possibility of divesting its United States division, Meda Pharmaceuticals, to raise funds for expansion in other areas.[2]

Meda
acquired

Rottapharm Madaus (2014)

gollark: It can do all the stuff you mention, probably, if you have a lot of computers and I/O devices! But it requires someone, somewhere, to have put in work.
gollark: I guess in some sense that's "commands", but complicated fiddly ones.
gollark: The only way to make it do things is to *program it*, or I guess to use someone else's code.
gollark: You cannot just type in what you want done, maybe with more underscores or something, and expect it to work.
gollark: There are no "commands" to magically make it do exactly what you want.

References

  1. "About Meda". Meda AB. Retrieved 15 August 2015.
  2. Ewing, Adam; Baigorri, Manuel (27 August 2015). "Swedish Drugmaker Meda Said to Weigh Sale of U.S. Operations". Bloomberg Business. Retrieved 28 August 2015.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.